Anixa Biosciences Unveils Phase II Study Plan for Breast Cancer Vaccine

Anixa Biosciences, Inc. announced its strategic plan for a Phase II study for its breast cancer vaccine. The Phase I trial is being conducted at Cleveland Clinic, funded by a grant from the US Department of Defense.